Beyfortus™(Nirsevimab) for RSV prevention
IWK Health manages the utilization of nirsevimab in Nova Scotia for the prevention of respiratory syncytial virus (RSV) infection in infants. For information regarding the guidelines for the use of this new product and the request approval process, please go to the nirsevimab section of the IWK Health website or contact:
Karen Chestney, RN
Provincial RSV Monitoring Nurse
IWK Health
(902) 470-2723
Date Revised:
November, 2024